U.S. federal trademark · Serial No. 99484781
The use of proprietary artificial intelligence to analyze the probability of success of a proposed FDA clinical trial with respect to a certain drug molecule in order for the owner or licensee of such molecule to evaluate the financial and other feasibility of proceeding with such clinical trial before committing financial and other resources to the clinical trial
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.